I suspect the board is taking extra risks to try to avoid...

I suspect the board is taking extra risks to try to avoid diluting the main shareholder. If so - this would be one of the bad psychological reasons to avoid taking the medicine - the sunk cost fallacy. I wonder if the CEO is happy about needing to moderate growth plans for a time?

The news is out, the Share price has reacted significantly already. Seems a bad time to add risk. Might be time for a renounce-able 1:1 at $1.10 or something like that, and get on the front foot. Otherwise the market may also start to be concerned that a more desperate dilutive placement at that sort of price could take place, diluting all of the plebs equity etc.

I hope the Sep quarter has been as expected! Time for an update IMO.

All IMO